These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 24259687)
1. Multivariate analysis of factors associated with persistent colesevelam treatment among patients with hypercholesterolemia. Romanelli RJ; Leahy A; Jukes T; Ye X; Kang A; Ishisaka DY Ann Pharmacother; 2013 Oct; 47(10):1247-52. PubMed ID: 24259687 [TBL] [Abstract][Full Text] [Related]
2. Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network. Romanelli RJ; Leahy A; Jukes T; Ye X; Qian C; Ishisaka DY Curr Med Res Opin; 2013 Dec; 29(12):1747-56. PubMed ID: 24024750 [TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe. Bays H; Rhyne J; Abby S; Lai YL; Jones M Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial. Insull W; Toth P; Mullican W; Hunninghake D; Burke S; Donovan JM; Davidson MH Mayo Clin Proc; 2001 Oct; 76(10):971-82. PubMed ID: 11605698 [TBL] [Abstract][Full Text] [Related]
5. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI. Ye X; Qian C; Liu J; St Peter WL Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study. Knopp RH; Tsunehara C; Retzlaff BM; Fish B; Nguyen H; Anderson S; Nguyen T Metabolism; 2006 Dec; 55(12):1697-703. PubMed ID: 17142146 [TBL] [Abstract][Full Text] [Related]
7. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ; Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients. Davidson M Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045 [TBL] [Abstract][Full Text] [Related]
9. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus. Brunetti L; Hermes-Desantis ER Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Goldberg RB; Fonseca VA; Truitt KE; Jones MR Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. Schwab P; Louder A; Li Y; Mallick R; Bays H Drugs Aging; 2014 Sep; 31(9):683-94. PubMed ID: 25091271 [TBL] [Abstract][Full Text] [Related]
12. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol. Corsini A; Windler E; Farnier M Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992 [TBL] [Abstract][Full Text] [Related]
13. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Bays HE; Davidson M; Jones MR; Abby SL Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of colesevelam in type 2 diabetes mellitus. Brunetti L; Campbell RK J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819 [TBL] [Abstract][Full Text] [Related]
17. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes. Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418 [TBL] [Abstract][Full Text] [Related]
18. Colesevelam (Welchol) for hypercholesterolemia. Med Lett Drugs Ther; 2000 Oct; 42(1091):102-4. PubMed ID: 11056044 [No Abstract] [Full Text] [Related]
19. Colesevelam: a review of its use in hypercholesterolemia. Robinson DM; Keating GM Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213 [TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes. Avitabile N; Banka A; Fonseca VA Expert Opin Drug Saf; 2011 Mar; 10(2):305-10. PubMed ID: 21244342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]